Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11414494
Anti-GITR antibodies and uses thereof
granted -
US 11407813
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11407822
Treatment of fibrodysplasia ossificans progressiva
granted -
US 11396544
Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof
granted -
US 11384153
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
granted -
US 11377502
Anti-MSR1 antibodies and methods of use thereof
granted -
US 11370843
High affinity antibodies to human IL-6 receptor
granted -
US 11369896
Methods for quantitating individual antibodies from a mixture
granted -
US 11365265
Anti-C5 antibody combinations and uses thereof
granted -
US 11359246
Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors
granted -
US 11352446
Methods of making multispecific antigen-binding molecules
granted -
US 11351256
Room temperature stable lyophilized protein
granted -
US 11352417
Method of treating an allergy with allergen-specific monoclonal antibodies
granted -
US 11345715
Biologically active molecules, conjugates thereof, and therapeutic uses
granted -
US 11331332
Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors
granted -
US 11319375
Methods and compositions for treating subjects having rheumatoid arthritis
granted -
US 11306148
Anti-NPR1 antibodies and uses thereof
granted -
US 11306155
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
granted -
US 11306135
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11299532
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11292847
Methods for treating atopic dermatitis by administering an IL-4R inhibitor
granted -
US 11292842
Anti-PD-1 antibodies for treatment of lung cancer
granted -
US 11291636
Polymer protein microparticles
granted -
US 11286290
Anti-VEGF protein compositions and methods for producing the same
granted